Connect with us

business

Zurich Set to Get Stoned in Switzerland Cannabis Trials

Published

on


The news came out a few days ago. Not an official go-ahead to begin, but a final approval for the much-anticipated Switzerland recreational cannabis trials; the trials that will help determine recreational cannabis policy for an upcoming weed market in the country. The trials are still yet to begin, but more information is now available for what to expect; and the final barrier for it to happen, broken through.

What are the Switzerland recreational cannabis trials?

There are two things happening in Switzerland concerning recreational cannabis, but they’re heavily related. For one, Switzerland decided via a Council of States vote in September, 2021, that recreational cannabis shouldn’t be prohibited anymore. This was just a basic decision, and without any legislation to define what this would look like for the country. As a part of the vote, Switzerland’s parliament must now draft a bill for recreational cannabis.

The second thing started prior to this in 2020, when a pilot study to assess whether current cannabis laws should be updated, was approved. The amended Federal Act on Narcotics and Psychotropic Substances went into effect in May of 2021, and allows trials to be held related to recreational cannabis in the country. The approved period for trials as per the legislation, is 10 years, but its not expected to take that long to establish policy.

The vote for legalization happened before any trial began (or was fully approved), which shows the emphasis went to ‘how to do it’ from ‘should we do it’. According to the study FAQ for the Zurich trials, this particular study will last 3.5 years. It’s quite possible that separate trials will get approved in another part of the country. The amendment is broad in that way, allowing for different research projects. This is the first to get underway.


Welcome, thanks for being here. Check out the Cannadelics Weekly Newsletter to access e-mail updates; and for a load of deals on cannabis buds, vapes and smoking paraphernalia, edibles, cannabinoid compounds (including HHC), amanita mushroom extracts, and so, so much more. Come get what you need to feel good.


According to stadt-zuerich.ch, the study site, “The study examines the effects of purchasing selected cannabis products from controlled cultivation under regulated conditions on the consumption and health of the participants. In addition, different models of regulated cannabis procurement are to be compared with one another.”

The study is run by the city of Zurich in conjunction with the Psychiatric University Clinic Zurich. The study is called ‘Cannabis With Responsibility’ (Züri Can), and will only use a single location: Zurich, the capital city of Switzerland. All participants are to come from this location.

The study was supposed to begin at the end of 2022, but was postponed to an unspecified date in 2023. This happened because the Federal Office of Public Health and the Cantonal Ethics Commission, still needed to approve at the time it was supposed to begin. It was stated upon postponement that the cannabis needed for the trials, couldn’t be procured until approvals were met. The trials did finally get approved on March 21st, and are now said to begin after the summer holidays.

The low-down on recreational cannabis trials in Switzerland

The trials are not open to everyone in Zurich who want to smoke, and will only include a test group of 2,100 people. These 2,100 people will be able to legally buy weed for recreational use, in regulated amounts. The 2,100 alone will have access to pharmacies, dispensaries, and social clubs within Zurich, with 21 access points; though each participant must choose only one access point, and stick with it.

These access points can’t mess with pricing. All prices are formulated using current black market prices, along with consideration to THC and CBD content within a product. All supply points must sell at the same price for the same product, which is set by the study’s management. And all products used in the study must come from organic cannabis, produced in Switzerland. Cannabis cannot be consumed in public.

How will the government get anything out of this? Study subjects must fill out a survey every six months that goes over their general use habits, and whatever effects their use has on their health. The data from the study is meant to be released starting next year, and on a rolling basis (as the study progresses, not solely at the end of it).

Switzerland's cannabis trial participants fill out use and health surveys
Switzerland’s cannabis trial participants fill out use and health surveys

Explained Barbara Burri, Zurich municipal health department project manager, via CNBC “The idea is to get robust real world evidence that serves policymaking for new [national] regulation on cannabis.” The part of the study is to assess the best ways to go about cannabis legalization, in order to create a compatible environment between this new industry, and the general well-being of the public.

If you’re a resident of Zurich who wants to be a part of this, you can register to participate. In order for consideration, you must already be a cannabis user, and an adult. You must not have underlying medical problems, and you may not participate if you’re employed as a driver. Anyone who fits this description, and is interested, can check out the registration, here.

What does the 2,100 represent?

2,100 people in the general Zurich area will be picked to participate in the upcoming recreational cannabis trials as a way to determine the best way to open a recreational market in Switzerland. Study trials of any kind aren’t meant to include everyone. They’re groups meant to represent wider populations. The idea being that a program that meets the needs of the chosen group, will also meet the needs of the wider population.

According to public health surveys out of Switzerland, via CNBC, about a third of the country has at least experimented with cannabis. It’s estimated that out of Zurich city proper’s 420,000+ residents, that approximately 13,000 regularly consume cannabis. Like many other cities, that 420,000+ only relates to people within city lines, not the entire metropolitan area that accounts for more like 1.4 million.

According to swissinfo.ch (SWI), there are approximately 220,000 regular cannabis users in the country. A 2016 estimate put it at 500,000, which is a pretty big difference, and perhaps, highlights how hard it is for governments to pin down numbers for illegal drug use. While the number could have dropped by over half in about six years (at a time when things are getting more liberal), its more likely that neither is exactly correct. I couldn’t find a publication of the latter number beyond the 2016 srf.ch article, which seemed a bit slanted against drug use in general. The 500,000 could be an inflated number that was used to incite fear.

This number discrepancy might also relate to specific definitions. Swissinfo’s number was specifically for ‘regular users.’ If the 500,000 relates to number of people who have tried cannabis at some point, for example, the numbers then make more sense.

Cannabis use in Switzerland
Cannabis use in Switzerland

Numbers often vary on these topics because of the difficulty in getting hard statistics; I’m putting attention on this discrepancy because the numbers are far enough off that one is over half the other. However, let’s remember CNBC put it at 1/3 of Switzerland’s adult population that had at least ‘tried’ cannabis (meaning millions), which then brings us back to the original issue, of not totally understanding what the use population is.

Switzerland has approximately 8.8 million inhabitants in 2023 as per worldometers. That means, if looking at the lower number, about 2.5% of the population regularly uses weed. If looking at the high number, about 5.6% of the population are regular users. This, of course looks at the comparison to the entire population, not just the adult population. Although one of the realities of cannabis, is that many under-agers use it too. And many people use it, while not being ‘regular users’. Overall, for a city with approximately 13,000 regular users, 2100 is a great representative sample.

Conclusion

The Switzerland cannabis trials haven’t started yet, but we’re now getting closer, with a final approval from necessary agencies. Considering Switzerland already announced a legalization, its questionable how necessary this study is, at least in terms of initial legislation.

With the way things are going, a market will open long before this study ends (particularly as Switzerland competes with Germany). This study might not be the basis for whatever legislation passes first, but its sure to be useful in effectively building a system; especially considering how many issues prevail in today’s cannabis market.

Hello readers! Thanks for being here with us at Cannadelics.com; where we work to bring you the best in independent reporting for the growing cannabis and psychedelics spaces. Come our way to stay informed on everything important, and subscribe to the Cannadelics Weekly Newsletter, so you’re never late to get the news.



Source link

Continue Reading

business

Astronauts to Test Cannabis Growth in Outer Space

Published

on

By


NASA‘s recent collaboration with the International Space Research Consortium to launch a mission testing the cultivation of cannabis in the microgravity of space has stirred a whirlwind of interest and controversy across the globe. This initiative aims to unravel the mysteries of how low-gravity environments affect plant growth, with cannabis serving as the pioneering subject. According to Dr. Alfred Terra, the esteemed lead scientist spearheading the project, the conditions in space present an “unparalleled opportunity” to push the boundaries of our understanding of botany and its applications in medicine and agriculture beyond Earth’s confines.

This ambitious endeavor aims to shed light on the potential for utilizing space-based agriculture to support long-duration space missions and future colonization efforts on other planets. The choice of cannabis as a research subject is particularly intriguing due to its complex biochemical makeup and its increasing use in medicinal therapies on Earth. Insights gained from how cannabis adapts to space’s harsh environment could lead to breakthroughs in growing food and medicinal plants in extraterrestrial colonies.

Despite the scientific excitement surrounding the mission, the announcement has been met with its share of skepticism and criticism. Some members of the scientific community and the general public question the allocation of resources toward cannabis research in space, arguing that more pressing scientific and exploratory questions merit attention aboard the International Space Station (ISS). These critics call for a focus on projects that directly contribute to our understanding of space travel’s impacts on human physiology or further our knowledge of the cosmos.

However, the space agencies involved have been quick to highlight the broader implications of this research. They argue that studying cannabis growth in microgravity could offer invaluable insights into plant biology, stress responses, and the possibility of cultivating a variety of crops in space, which are crucial for the long-term sustainability of space exploration and eventual human settlement on other planetary bodies.

Amidst the debates over the mission’s merits and the speculation spurred by its announcement date—April 1st—lies a deeper curiosity about the future of space exploration and the role of innovative agricultural research in that journey. The timing has led some to question the announcement’s authenticity, pondering whether it could be an elaborate April Fool’s Day jest aimed at sparking discussion or simply a coincidence that has amplified the public’s fascination with the project.

Whether viewed as a bold step into the future of space agriculture or a controversial choice of research focus, the mission symbolizes a growing intersection between space exploration and the quest to understand and utilize biological processes in unprecedented environments. As the launch date approaches and preparations continue, the world watches, eager to see what insights this venture might unfold about cannabis, plant science, and the potential for life beyond Earth.

*** This article is an April Fool’s Day joke ***



Source link

Continue Reading

business

A Hiring Wave on the Horizon

Published

on

By


The U.S. cannabis industry is on the brink of a significant hiring wave in 2024, spurred by a 12% increase in legal sales in 2023, reaching $29 billion. This growth, alongside potential federal reclassification of cannabis, is expected to create up to 100,000 new jobs, particularly in the retail sector, where 93% of companies plan to expand their workforce. The Vangst 2024 Cannabis Salary Guide highlights an industry ready to bounce back from previous economic stagnation, with a strong emphasis on experience, adaptability, and cultural fit in prospective employees.

The cannabis sector is poised for a massive expansion in employment opportunities in 2024, following a year of economic challenges and layoffs. This optimistic forecast comes from Vangst’s latest industry salary guide, which anticipates a hiring boom driven by increased legal cannabis sales and the potential for federal rescheduling. The anticipated move to reclassify cannabis to Schedule III could significantly reduce tax burdens, increase company valuations, and attract more investors, according to Viridian Capital Advisors.

Retail cannabis companies are at the forefront of this hiring surge, with nearly all surveyed indicating plans to bolster their teams in response to growing demand and market expansion. The focus is not just on filling positions but on finding candidates who can navigate the evolving legal and market landscape, prioritize cultural fit, and possess strong communication skills over traditional qualifications.

Salaries in the cannabis industry have also seen an uptick, with top-end wages growing by 4.7%, outpacing the national non-cannabis average. However, the sector still trails behind others in offering comprehensive benefits packages, a gap that affects employee satisfaction and retention. The demand for health insurance and better work-life balance is clear among job seekers in the cannabis space.

Diversity and inclusion are gaining traction within cannabis company hiring practices, with a significant portion of companies implementing strategies to create a more inclusive workforce. The industry’s employment of veterans and individuals with disabilities highlights its diverse nature, but there remains room for improvement.

Why It Matters: This hiring wave marks a pivotal moment for the cannabis industry, signaling a shift towards recovery and growth after a period of stagnation. It underscores the industry’s resilience and its potential to contribute significantly to the economy through job creation and increased sales.

Potential Implications: The anticipated hiring boom in the cannabis industry could lead to wider acceptance and normalization of cannabis use, further influencing policy changes and societal attitudes. Additionally, the focus on diversity and inclusion could set a precedent for other sectors, promoting a more inclusive workforce across industries.

Source: Green Market Report



Source link

Continue Reading

business

86% of Californians Support Legal Cannabis Markets

Published

on

By


A recent survey conducted by the California Department of Cannabis Control (DCC) and FM3 Research reveals that a significant majority of Californians, 86%, believe it’s important to purchase cannabis from legal markets. The survey also indicates growing support for Proposition 64 and highlights the need for consumer education on legal cannabis procurement.

California, a pioneer in legalizing medical cannabis in 1996 and later adult-use cannabis in 2016, has developed into the world’s largest cannabis market. The DCC’s Real California Cannabis Campaign, aimed at guiding consumers to licensed dispensaries, commissioned FM3 Research to survey over 1,000 California adults to gauge their attitudes towards the state’s cannabis market. Key findings include:

  • 62% view Proposition 64 positively, suggesting increased support for cannabis reform.
  • 86% of respondents stress the importance of buying cannabis from legal sources.
  • 72% feel consumers should ensure they’re purchasing from licensed retailers.
  • Despite the legal market’s size, illegal sales remain prevalent, with two-thirds of cannabis sales in 2022 coming from the illicit market.
  • The California Unified Cannabis Enforcement Taskforce (UCETF) reported significant seizures in 2023, including over $312 million in illegal cannabis and 119 firearms, showcasing efforts to combat illegal operations.
  • The survey uncovered education gaps, with 85% of respondents in areas where retail cannabis is banned either misinformed or unaware of local cannabis laws.
  • Opinions on identifying licensed retailers were divided, with 44% finding it easy and 42% finding it challenging.

Why It Matters: This survey underscores the growing acceptance of legal cannabis markets among Californians and the critical role of consumer education in supporting legal operations. It highlights the ongoing battle against illicit sales and the importance of regulatory efforts to ensure a safe, legal cannabis market.

Potential Implications: The findings could influence future cannabis policies in California, emphasizing the need for public education campaigns and stricter enforcement against illegal operations. It also suggests a potential shift in consumer behavior towards supporting legal cannabis sources, which could further legitimize and stabilize the legal market.

Source: High Times



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media